Aimedis - the best ehealth project in cryptospace 
Topic: ✅✅✅[AIRDROP][PRESALE][ANN] Aimedis the future of heathcare✅✅✅ (Read 183 times)
-Reserved-
-Reserved-
For our ongoing Airdrop please visit the following website:
https://aim.aimedis.com/airdrop
There is no need to post in this thread to join the Airdrop!
https://aim.aimedis.com/airdrop
There is no need to post in this thread to join the Airdrop!
Aimedis https://aimedis.com/
ICO https://aim.aimedis.com/
Airdrop https://aim.aimedis.com/airdrop
Telegram https://t.me/aimedistoken
Twitter https://twitter.com/aimedisglobal
Whitepaper https://aim.aimedis.com/pdf/WhitepaperEN10.pdf
Overview of Aimedis
What is Aimedis?
Aimedis is the next generation e-health platform which will connect the efficiency of AI and the
security of Blockchain to provide cutting edge medical and psychological support. Aimedis is a
platform which will enable patients and doctors to connect with each other 24/7 from
everywhere on the planet while offering never before seen security for patient's personal medical
and psychological data.
The dual blockchain design
The Aimedis security system is based on a dual blockchain architecture, allowing Aimedis users
to keep ownership of their medical data while allowing them to monetize their private data for
medical research purposes or pay for medical services and medication while getting great
discounts by using the AIM token. Medical researchers will be granted only as much or as little
confidential data as desired by the patient in a completely anonymized way, protecting the
patient's sensitive information while allowing them to both profit and contribute to medical
research. The AIMchain private blockchain will make trust visible for the patient and the users
and will finally empower the patient via decentralisation and incentivising.
Connected Patient Communities
Aimedis helps connect patients in to communities using a unique social network system.
Aimedis will provide a dedicated space for patients to share their experiences,
recommendations, feedback, and advice with other patients. By coming together as a
community, patient's benefit from sharing their experiences and in offering support to each other.
This helps in dealing with acceptance and treatment of medical conditions.
The members of this community will have rich media capabilities such as uploading video,
audio, text, or image content, allowing them to connect with their peers. This media and content
is part of a creation-incentivized rewards system where creators of high quality content can be
rewarded by the other community members with votes.
As a community, members will be able to offer financial incentives (via voting) for content
published on the platform. Patient's can use their tokens to pay for services, transact within the
community, or exchange to fiat.
Secondarily, this content will be used as data inputs for our Artificial Intelligence when creating
extensive reports on specific medical conditions and diagnosis. This data is appended
alongside wearables data, scientific data, and more.
Already a proven existing company
Aimedis is an existing company, which operates today in three countries:
Germany, Netherlands and Thailand.
Aimedis works today with several hospital chains as a technology provider
working with medical data, and has helped more than ten thousand patients.
Helping people all over the world
E-healthcare has the potential to help billions of people from impoverished areas and victims of
natural disasters. E-healthcare helps to raise the quality of life and financial cost in first world
countries. Aimedis is positioned for this emerging market and thanks to its dual blockchain
design brings true security and privacy to patient's data. Based on anonymized data gathering,
new discoveries and cures can be found at an accelerated pace, while patient's are financially
rewarded for allowing their data to be used in medical research studies.
ICO details
In cooperation with swisscom | Blockchain
Pre-Sale: May 15th 2018 07:00 UTC - June 26th 2018 07:00 UTC
ICO: June 27th 2018 07:00 UTC - September 5th 2018 07:00 UTC
Whitelisting for Pre-Sale started:
Register here
Discount:
Pre-Sale - 40% | Stage Total: 2.000.000 $
Pre-ICO - 20% | 25% if more than 40 ETH, 35% if more than 100 ETH | Stage Total: 9.000.000 $
ICO | Stage Total: 27.000.000 $
1 AIM = 0,12 $
Softcap: 9.000.000 $
Hardcap: 36.000.000 $
Total Supply: 600.000.000 AIM
Tokens for sale: 300.000.000 AIM
Unsold tokens will be burned.
✓ Token type: ERC20 based token on Ethereum public blockchain
✓ Maximum supply: 600.000.000 token
✓ Available for purchase: 300.000.000 token
✓ Price per token: 0,12 USD = 1 AIM
✓ Emission rate: No new coins will be minted, created or mined after the ICO
✓ Vesting period for team tokens will be fix over at 12 months
✓ 20% of Aimedis revenue will directly flow into the AIMsocial fund
✓ Token can be used to pay services inside the platform and medication in the
AIMedisafe backed online drugstore with discounts
✓ Token will be used to reward participants in terms of sharing usefully voted content
on AIMsocial - our own medical social network
✓ The token enables the user to contribute to content creators via upvote + direct
contribution
✓ Researchers will pay patients for participating in trials via the token
✓ Token issuance during presale and ICO via Swisscom blockchain portal, which will
issue them directly after contribution
✓ Legal surveillance by Wenger & Vieli attorneys at law, Zürich & Zug, Switzerland
AIM tokens will be listed on major exchanges after the ICO.
What is Aimedis?
Aimedis is the next generation e-health platform which will connect the efficiency of AI and the
security of Blockchain to provide cutting edge medical and psychological support. Aimedis is a
platform which will enable patients and doctors to connect with each other 24/7 from
everywhere on the planet while offering never before seen security for patient's personal medical
and psychological data.
The dual blockchain design
The Aimedis security system is based on a dual blockchain architecture, allowing Aimedis users
to keep ownership of their medical data while allowing them to monetize their private data for
medical research purposes or pay for medical services and medication while getting great
discounts by using the AIM token. Medical researchers will be granted only as much or as little
confidential data as desired by the patient in a completely anonymized way, protecting the
patient's sensitive information while allowing them to both profit and contribute to medical
research. The AIMchain private blockchain will make trust visible for the patient and the users
and will finally empower the patient via decentralisation and incentivising.
Connected Patient Communities
Aimedis helps connect patients in to communities using a unique social network system.
Aimedis will provide a dedicated space for patients to share their experiences,
recommendations, feedback, and advice with other patients. By coming together as a
community, patient's benefit from sharing their experiences and in offering support to each other.
This helps in dealing with acceptance and treatment of medical conditions.
The members of this community will have rich media capabilities such as uploading video,
audio, text, or image content, allowing them to connect with their peers. This media and content
is part of a creation-incentivized rewards system where creators of high quality content can be
rewarded by the other community members with votes.
As a community, members will be able to offer financial incentives (via voting) for content
published on the platform. Patient's can use their tokens to pay for services, transact within the
community, or exchange to fiat.
Secondarily, this content will be used as data inputs for our Artificial Intelligence when creating
extensive reports on specific medical conditions and diagnosis. This data is appended
alongside wearables data, scientific data, and more.
Already a proven existing company
Aimedis is an existing company, which operates today in three countries:
Germany, Netherlands and Thailand.
Aimedis works today with several hospital chains as a technology provider
working with medical data, and has helped more than ten thousand patients.
Helping people all over the world
E-healthcare has the potential to help billions of people from impoverished areas and victims of
natural disasters. E-healthcare helps to raise the quality of life and financial cost in first world
countries. Aimedis is positioned for this emerging market and thanks to its dual blockchain
design brings true security and privacy to patient's data. Based on anonymized data gathering,
new discoveries and cures can be found at an accelerated pace, while patient's are financially
rewarded for allowing their data to be used in medical research studies.
ICO details
In cooperation with swisscom | Blockchain
Pre-Sale: May 15th 2018 07:00 UTC - June 26th 2018 07:00 UTC
ICO: June 27th 2018 07:00 UTC - September 5th 2018 07:00 UTC
Whitelisting for Pre-Sale started:
Register here
Discount:
Pre-Sale - 40% | Stage Total: 2.000.000 $
Pre-ICO - 20% | 25% if more than 40 ETH, 35% if more than 100 ETH | Stage Total: 9.000.000 $
ICO | Stage Total: 27.000.000 $
1 AIM = 0,12 $
Softcap: 9.000.000 $
Hardcap: 36.000.000 $
Total Supply: 600.000.000 AIM
Tokens for sale: 300.000.000 AIM
Unsold tokens will be burned.
✓ Token type: ERC20 based token on Ethereum public blockchain
✓ Maximum supply: 600.000.000 token
✓ Available for purchase: 300.000.000 token
✓ Price per token: 0,12 USD = 1 AIM
✓ Emission rate: No new coins will be minted, created or mined after the ICO
✓ Vesting period for team tokens will be fix over at 12 months
✓ 20% of Aimedis revenue will directly flow into the AIMsocial fund
✓ Token can be used to pay services inside the platform and medication in the
AIMedisafe backed online drugstore with discounts
✓ Token will be used to reward participants in terms of sharing usefully voted content
on AIMsocial - our own medical social network
✓ The token enables the user to contribute to content creators via upvote + direct
contribution
✓ Researchers will pay patients for participating in trials via the token
✓ Token issuance during presale and ICO via Swisscom blockchain portal, which will
issue them directly after contribution
✓ Legal surveillance by Wenger & Vieli attorneys at law, Zürich & Zug, Switzerland
AIM tokens will be listed on major exchanges after the ICO.
Jump to: